ArticleESMO open2025

Impact of the Lung Immune Prognostic Index in non-small-cell lung cancer patients with PD-L1-low/negative tumors receiving chemoimmunotherapy: a real-world multicenter retrospective study.

A Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.